姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Chen,Guo-Bao | Chairman | 0.83% | Yonglin Capital Holding Co., Ltd. |
Zheng,Rong-Huang | Director | 0.83% | Yonglin Capital Holding Co., Ltd. |
Qiu,Xin-Yi | Independent Director | 0.00% | |
Wang,Mei-Jun | Independent Director | 0.00% | |
Wu,Jing-Heng | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 30,000,508 | 75,823,742 | 74,533,131 |
Operating cost | 28,710,961 | 71,003,743 | 68,806,707 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 1,289,547 | 4,819,999 | 5,726,424 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 1,289,547 | 4,819,999 | 5,726,424 |
Operating expenses | 752,413 | 3,248,849 | 4,258,374 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 537,134 | 1,571,150 | 1,468,050 |
Non-operating income and expenses | 675,123 | 2,963,482 | 3,880,091 |
Net profit (loss) before tax | 1,212,257 | 4,534,632 | 5,348,141 |
Income tax expense (benefits) | 275,867 | 1,134,322 | 1,034,095 |
Net profit (loss) of ongoing business for the current period | 936,390 | 3,400,310 | 4,314,046 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 936,390 | 3,400,310 | 4,314,046 |
Other comprehensive profit (loss), net | 1,895,010 | 3,757,886 | 52,115 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 2,831,400 | 7,158,196 | 4,366,161 |
Net profit (loss) attributable to owners of parent company | 953,376 | 3,584,397 | 4,260,720 |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | -16,986 | -184,087 | 53,326 |
Comprehensive profit (loss) attributable to owners of parent company | 2,855,675 | 7,378,298 | 4,311,667 |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | -24,275 | -220,102 | 54,494 |
Basic earnings per share (yuan) | 0 | 2 | 3 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | 748,703 | 2,690,428 | -3,545,781 |
Net cash inflows (outflows) from investing activities | -213,386 | -37,643,842 | -25,366,535 |
Net cash inflow (outflow) from financing activities | 7,506 | -3,734,788 | -1,443,402 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 233,419 | 1,352,782 | -391,926 |
Increase (decrease) in cash and cash equivalents in the current period | 776,242 | -37,335,420 | -30,747,644 |
Beginning balance of cash and cash equivalents | 9,918,179 | 47,253,599 | 78,001,243 |
Ending balance of cash and cash equivalents | 10,694,421 | 9,918,179 | 47,253,599 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 129,888,815 | 129,863,970 | 74,742,426 |
Non-current asset | 37,219,808 | 37,004,004 | 59,350,970 |
Total asset | 167,108,623 | 166,867,974 | 134,093,396 |
Current liability | 55,026,214 | 55,612,334 | 27,946,085 |
Non-current liability | 1,028,426 | 1,051,918 | 987,133 |
Total liability | 56,054,640 | 56,664,252 | 28,933,218 |
share capital | 14,144,852 | 14,144,852 | 14,144,852 |
Equity - secruity token | - | - | - |
capital reserve | 7,577,443 | 7,578,303 | 7,571,060 |
retained earning | 92,360,167 | 93,386,662 | 87,427,672 |
Other equity | -2,658,017 | -4,559,908 | -3,857,321 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | 111,424,445 | 110,549,909 | 105,286,263 |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | -370,462 | -346,187 | -126,085 |
Total Equity | 111,053,983 | 110,203,722 | 105,160,178 |
Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 78 | 78 | 74 |
標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
---|---|---|---|---|
無線心電圖血氧監視系統1組 | 國立臺灣大學醫學院附設醫院新竹臺大分院 | 112/10/26 | 否 |